1. Home
  2. INM vs GEOS Comparison

INM vs GEOS Comparison

Compare INM & GEOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • GEOS
  • Stock Information
  • Founded
  • INM 1981
  • GEOS 1980
  • Country
  • INM Canada
  • GEOS United States
  • Employees
  • INM N/A
  • GEOS N/A
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • GEOS Industrial Machinery/Components
  • Sector
  • INM Health Care
  • GEOS Industrials
  • Exchange
  • INM Nasdaq
  • GEOS Nasdaq
  • Market Cap
  • INM 3.2M
  • GEOS 72.9M
  • IPO Year
  • INM N/A
  • GEOS 1997
  • Fundamental
  • Price
  • INM $2.75
  • GEOS $12.40
  • Analyst Decision
  • INM
  • GEOS
  • Analyst Count
  • INM 0
  • GEOS 0
  • Target Price
  • INM N/A
  • GEOS N/A
  • AVG Volume (30 Days)
  • INM 5.7M
  • GEOS 500.4K
  • Earning Date
  • INM 05-12-2025
  • GEOS 08-07-2025
  • Dividend Yield
  • INM N/A
  • GEOS N/A
  • EPS Growth
  • INM N/A
  • GEOS N/A
  • EPS
  • INM N/A
  • GEOS N/A
  • Revenue
  • INM $4,920,990.00
  • GEOS $116,542,000.00
  • Revenue This Year
  • INM N/A
  • GEOS N/A
  • Revenue Next Year
  • INM N/A
  • GEOS N/A
  • P/E Ratio
  • INM N/A
  • GEOS N/A
  • Revenue Growth
  • INM N/A
  • GEOS N/A
  • 52 Week Low
  • INM $1.72
  • GEOS $5.51
  • 52 Week High
  • INM $15.70
  • GEOS $18.99
  • Technical
  • Relative Strength Index (RSI)
  • INM 46.31
  • GEOS 55.56
  • Support Level
  • INM $2.66
  • GEOS $12.60
  • Resistance Level
  • INM $2.97
  • GEOS $14.38
  • Average True Range (ATR)
  • INM 0.37
  • GEOS 1.80
  • MACD
  • INM -0.05
  • GEOS -0.32
  • Stochastic Oscillator
  • INM 15.12
  • GEOS 38.67

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.

Share on Social Networks: